Industry reports
Editor highlights

Publication dates

data types

Multiple Sclerosis Market and Forecasts, April 2014

You might be interested in: medicine, drug, stem cell, more »


 
1-10 of about 200 reports for Multiple Sclerosis

Multiple Sclerosis Market (multiple sclerosis, colorectal cancer, neck cancer) in The United States

  • Industry report
  • January 2012
  • 25 pages

... Strengthened with seasoned senior executives Tough pipeline s taken Continued actions to strengthen and defend leadership positions in multiple sclerosis and oncology Definition of new r ...

Autoimmune Disease Sector (autoimmune disease, cancer, musculoskeletal disorder) in The United States

  • Industry report
  • January 2012
  • 28 pages

... If approved, allow it to be positioned in a variety of autoimmune disorders, including inflammatory bowel diseases and multiple sclerosis as well as other potential disorders such as rheumatoid arthritis ...

Pharmaceutical in The United States : Innovation and Technology Trends

  • Industry report
  • June 2012
  • 191 pages
  • by Market Research Publisher

... For the treatment of relapsing-remitting multiple sclerosis (rrms), the most common form of ms. Bg-12 is the only currently known investigational compound for the treatment of rrms that has experimentally ...

Pharmaceutical : Innovation and Technology Trends

  • Industry report
  • February 2012
  • 21 pages
  • by Corporation

... Markets*: Nephrotic syndrome, multiple sclerosis, infantile spasms Several billion dollar market opportunity questcor overview 3 Profitable, cash flow positive, $115m** in cash, debt-free strategy ...

The British Pharmaceutical Business Analysis

  • Industry report
  • December 2012
  • 54 pages

... In neurological disorders many diseases linked to low vitamin d rickets - osteomalacia - muscle weakness - depression - dementia - infections - multiple sclerosis - osteoporosis - fractures - cancer ...

The British Pharmaceutical Business Analysis

  • Industry report
  • December 2012
  • 54 pages

... In neurological disorders many diseases linked to low vitamin d rickets - osteomalacia - muscle weakness - depression - dementia - infections - multiple sclerosis - osteoporosis - fractures - cancer ...

Infectious Disease Market in Poland and The United States

  • Industry report
  • September 2013
  • 24 pages

... Preclinical phase i phase ii phase iii relapsing-remitting multiple sclerosis trimesta tm oral estriol cognitive dysfunction in multiple sclerosis trimesta tm oral estriol c. Difficile infection ...

Pharmaceutical in The United Kingdom : Innovation and Technology Trends

  • Industry report
  • June 2012
  • 9 pages
  • by Research Paper

... sclerosis, pulmonary arterial hypertension, inflammation and tissue scarring Fp7 grant with university spinout diurnal ltd 5.56M project; 4.2M grant to develop paediatric hydrocortisone version ...

Pharmaceutical Sector in The United Kingdom

  • Industry report
  • December 2012
  • 44 pages

... Linked to low vitamin d rickets - osteomalacia - muscle weakness - depression - dementia - infections - multiple sclerosis - osteoporosis - fractures - cancer prevention - cancer progression ...

World Pharmaceutical Business Overview

  • Industry report
  • February 2012
  • 31 pages
  • by Corporation

... And other on-label markets for acthar financials: *in this presentation, the terms Nephrotic syndrome, multiple sclerosis, And Infantile spasms, And their abbreviations, refer to the on ...

» Purchase Premium Reports (From $ 125 - $ 9 995)

About 4 300 reports for Multiple Sclerosis

» Read our Company Profiles

1 Companies for Multiple Sclerosis

Roche Holding AG

Switzerland

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.